相关实验视频
Updated: Jun 3, 2025
07:16
Thermal Ablation for the Treatment of Abdominal Tumors
Published on: March 7, 2011
34.5K
在多模式治疗中包含的热性废除预测了晚期非小细胞肺癌的增强生存率:一种倾向性得分匹配结果研究
Stella Chin-Shaw Tsai1,2,3, Yi-Min Chen4, Yueh-Han Ku4
1Superintendent Office, Tungs' Taichung MetroHarbor Hospital, Taichung, Taiwan.
概括
添加热废除 (TA) 显著改善了晚期非小细胞肺癌 (NSCLC) 患者的生存率. 这种侵入性较小的选择提高了整体生存率和无进展生存率,为手术提供了可行的替代方案.
科学领域:
- 在瘤学瘤学.
- 干预性放射学 干预性放射学
背景情况:
- 晚期非小细胞肺癌 (NSCLC) 提出了治疗挑战.
- 对于晚期NSCLC患者存在有限的有效疗法.
研究的目的:
- 评估将热废除 (TA) 添加到高级NSCLC治疗方案的影响.
- 为了改善晚期NSCLC患者的生存结果.
主要方法:
- 从2008年至2020年,对1083名晚期非小细胞癌患者 (IIIB/IV期) 进行了回顾性队列研究.
- 用TA治疗和常规疗法治疗的患者之间的生存结果的比较.
- 倾向得分匹配和考克斯回归用于控制混因子.
主要成果:
- 热废除 (TA) 组的平均整体存活时间 (OS) (37个月与15个月) 和无进展存活时间 (PFS) (36个月与14个月) 显着更长.
- 五年OS率为32.4%与TA对比9.8%没有;五年PFS率为24.1%对比6.3%.
- TA改善了生存结果,特别是在与向治疗和化疗相结合时,并且与带切除术相当.
结论:
- 热切除菌 (TA) 在晚期NSCLC患者中显著改善OS和PFS.
- 对那些无法接受手术的患者来说,TA提供了一种可行的,不那么侵入性的治疗选择.
- 支持将TA纳入标准护理方案,等待进一步的前性研究.
更多相关视频
08:54Treatment of Liver Metastases Using an Internal Target Volume Method for Stereotactic Body Radiotherapy
Published on: May 8, 2018
14.2K
04:04Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer
Published on: February 12, 2017
10.4K
相关概念视频
02:57Targeted Cancer Therapies
7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.4K
02:50Combination Therapies and Personalized Medicine
4.8K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.8K